OClawVPS.com
Polaris Partners
Edit

Polaris Partners

https://www.polarispartners.com
Last activity: 19.03.2026
Active
Portfolio
14
Persons
41
Mentions
162
Employees: 11-50
Investment Stage: Series A

Portfolio 14

DateNameWebsiteTotal RaisedLocation
13.03.2026Tropictropic.bio$106.77MUnited Kin...
16.02.2026BiomEditbiomedit.com$42.9MUnited Sta...
04.11.2025Sovato Hea...sovato.com$41MUnited Sta...
24.05.2023Just a mom...larkspur.bio$35.5MUnited Sta...
22.03.2023EpiBiologi...epibiologics.com$157MUnited Sta...
04.11.2022FOLX Healt...folxhealth.com$80MUnited Sta...
20.07.2022Camp4camp4tx.com$175MUnited Sta...
27.06.2022Nomad Heal...nomadhealth.com$240MUnited Sta...
10.03.2021Tausighttausight.com$26MUnited Sta...
26.02.2021SpineZonespinezone.com$12MUnited Sta...
Show more

Persons 41

DateFirst NameLast NameTitleLinkedInLocation
-MarissaBertorelliPrincipallinkedin.c...-
-JoannaZesigerDirector o...-
-JonFlintFounding P...linkedin.c...-
-DarrenCarrollManaging P...-
-LaurenCrockettGeneral Co...linkedin.c...-
-JocelynLozanoExecutive ...-
-MollyWilsonExecutive ...linkedin.c...-
-KimPngPrincipal-
-SharifVakiliEntreprene...linkedin.c...-
-HaroldFriedmanChief Fina...linkedin.c...-
Show more

Mentions in press and media 162

DateTitleDescription
22.03.2026Crossbow Therapeutics Fuels T-Cell Engager Pipeline with $77 Million Series BCrossbow Therapeutics secured $77 million in Series B funding to propel its innovative TCR-mimetic antibody cancer therapies. This substantial capital injection will accelerate the development of critical T-cell engager programs. Funds will...
19.03.2026Crossbow Therapeutics Raises $77M in Series B FundingCrossbow Therapeutics, a Cambridge, MA-based biotechnology company developing antibody therapies to treat a broad range of cancers, raised $77M in Series B funding. The round was led by Taiho Ventures and Arkin Bio Capital, with participati...
18.03.2026Crossbow Therapeutics: $77 Million Raised To Advance TCR-Mimetic Antibody Cancer TherapiesCrossbow Therapeutics announced it has raised $77 million in a Series B financing to advance the development of its TCR-mimetic antibody therapies designed to treat a broad range of cancers. The funding round was co-led by Taiho Ventures an...
15.03.2026Tropic Secures $105M: Gene-Edited Crops Reshape Global Food FutureTropic, a UK AgTech firm, raised $105 million in Series C funding. This capital boosts gene-edited tropical crop expansion. Forbion and Corteva co-led the round. The focus is disease-resistant bananas and climate-resilient rice. Tropic's GE...
15.03.2026Tropic: $105 Million Raised To Scale Gene-Edited Tropical Crops And Banana ProductionTropic, a UK-based agricultural biotechnology company developing gene-edited tropical crops, has raised $105 million in an oversubscribed Series C funding round to accelerate global commercial expansion and scale production of its breakthro...
13.03.2026UK AgTech startup Tropic secures €91.3 million to bring gene-edited bananas and climate-resilient crops to marketTropic, a Norwich-based AgTech startup specialising in gene‑edited tropical crops, has announced the close of its oversubscribed €91.3 million ($105 million) Series C financing to accelerate the global scale-up of its banana and rice portfo...
16.02.2026IBJ Podcast: Here’s how BiomEdit raised $18.4M in a tough VC year-
01.02.2026Focus on biopharma comes at the right time: Industry-
31.01.2026TRexBio Secures $50M to Accelerate Treg-Targeted Immunotherapy PipelineTRexBio secured $50 million. This clinical-stage biotech develops precision immunoregulatory medicines. Its focus: tissue regulatory T cell (Treg) biology. Funding fuels clinical and preclinical pipeline advancement. Lead program TRB 061, a...
28.01.2026TRexBio: $50 Million Raised To Advance Tissue-Targeted Treg Immunology PipelineTRex Bio, a clinical-stage biotechnology company focused on precision immunoregulatory medicines derived from tissue regulatory T cell biology, announced it closed an oversubscribed $50 million financing to support clinical and preclinical ...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In